Global Primary Biliary Cholangitis Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	151 Pages	TechNavio	November, 2023	INF18338321

Best Price Guarantee
Price	from $2,500
Length	151 Pages
Publisher	TechNavio
Published Date	November, 2023
SKU	INF18338321

Global Primary Biliary Cholangitis Therapeutics Market 2024-2028

The primary biliary cholangitis therapeutics market is forecasted to grow by USD 346.85 mn during 2023-2028, accelerating at a CAGR of 8.75% during the forecast period. The report on the primary biliary cholangitis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by emergence of telehealth and remote monitoring, rising investments and developments in healthcare industry, and increase in product launches in primary biliary cholangitis therapeutics market.

Technavio's primary biliary cholangitis therapeutics market is segmented as below:

By Type

Primary drug
Secondary drug

By Distribution Channel

Drug stores and retail pharmacies
Hospital pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing demand for R&D due to government healthcare expenditure as one of the prime reasons driving the primary biliary cholangitis therapeutics market growth during the next few years. Also, increasing geriatric population and rise in the R and D investments in primary biliary cholangitis therapeutics by manufacturers will lead to sizable demand in the market.

The report on the primary biliary cholangitis therapeutics market covers the following areas:

Primary biliary cholangitis therapeutics market sizing
Primary biliary cholangitis therapeutics market forecast
Primary biliary cholangitis therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading primary biliary cholangitis therapeutics market vendors that include Abbott Laboratories, AbbVie Inc., Alkem Laboratories Ltd., Eli Lilly and Co., GENFIT SA, Glenmark Pharmaceuticals Ltd., ICE S.p.a., Intercept Pharmaceuticals Inc., Ipsen Pharma, Leeford Healthcare Ltd., NGM Biopharmaceuticals Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.. Also, the primary biliary cholangitis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Product; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global thoracic surgery market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global thoracic surgery market 2018 - 2022 ($ million); 4.2 End-user Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Product Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 30: Chart on End-user - Market share 2023-2028 (%); Exhibit 31: Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Exhibit 32: Chart on Comparison by End-user; Exhibit 33: Data Table on Comparison by End-user; 6.3 Hospitals - Market size and forecast 2023-2028; Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%); 6.4 Ambulatory surgical centers - Market size and forecast 2023-2028; Exhibit 38: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%); 6.5 Specialty clinics - Market size and forecast 2023-2028; Exhibit 42: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million); Exhibit 43: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million); Exhibit 44: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Exhibit 46: Market opportunity by End-user ($ million); Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product: 7.1 Market segments; Exhibit 48: Chart on Product - Market share 2023-2028 (%); Exhibit 49: Data Table on Product - Market share 2023-2028 (%); 7.2 Comparison by Product; Exhibit 50: Chart on Comparison by Product; Exhibit 51: Data Table on Comparison by Product; 7.3 CRM and cardiac assist devices - Market size and forecast 2023-2028; Exhibit 52: Chart on CRM and cardiac assist devices - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on CRM and cardiac assist devices - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on CRM and cardiac assist devices - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on CRM and cardiac assist devices - Year-over-year growth 2023-2028 (%); 7.4 Heart valve repair and replacement devices - Market size and forecast 2023-2028; Exhibit 56: Chart on Heart valve repair and replacement devices - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Heart valve repair and replacement devices - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Heart valve repair and replacement devices - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Heart valve repair and replacement devices - Year-over-year growth 2023-2028 (%); 7.5 Cardiopulmonary devices - Market size and forecast 2023-2028; Exhibit 60: Chart on Cardiopulmonary devices - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Cardiopulmonary devices - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Cardiopulmonary devices - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Cardiopulmonary devices - Year-over-year growth 2023-2028 (%); 7.6 Heart defect closure devices - Market size and forecast 2023-2028; Exhibit 64: Chart on Heart defect closure devices - Market size and forecast 2023-2028 ($ million); Exhibit 65: Data Table on Heart defect closure devices - Market size and forecast 2023-2028 ($ million); Exhibit 66: Chart on Heart defect closure devices - Year-over-year growth 2023-2028 (%); Exhibit 67: Data Table on Heart defect closure devices - Year-over-year growth 2023-2028 (%); 7.7 Other thoracic surgery devices - Market size and forecast 2023-2028; Exhibit 68: Chart on Other thoracic surgery devices - Market size and forecast 2023-2028 ($ million); Exhibit 69: Data Table on Other thoracic surgery devices - Market size and forecast 2023-2028 ($ million); Exhibit 70: Chart on Other thoracic surgery devices - Year-over-year growth 2023-2028 (%); Exhibit 71: Data Table on Other thoracic surgery devices - Year-over-year growth 2023-2028 (%); 7.8 Market opportunity by Product; Exhibit 72: Market opportunity by Product ($ million); Exhibit 73: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 77: Chart on Geographic comparison; Exhibit 78: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 France - Market size and forecast 2023-2028; Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 115: Market opportunity By Geographical Landscape ($ million); Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 117: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 118: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 119: Overview on factors of disruption; 11.4 Industry risks; Exhibit 120: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 121: Vendors covered; 12.2 Market positioning of vendors; Exhibit 122: Matrix on vendor position and classification; 12.3 Abbott Laboratories; Exhibit 123: Abbott Laboratories - Overview; Exhibit 124: Abbott Laboratories - Business segments; Exhibit 125: Abbott Laboratories - Key news; Exhibit 126: Abbott Laboratories - Key offerings; Exhibit 127: Abbott Laboratories - Segment focus; 12.4 AbbVie Inc.; Exhibit 128: AbbVie Inc. - Overview; Exhibit 129: AbbVie Inc. - Product / Service; Exhibit 130: AbbVie Inc. - Key news; Exhibit 131: AbbVie Inc. - Key offerings; 12.5 Becton Dickinson and Co.; Exhibit 132: Becton Dickinson and Co. - Overview; Exhibit 133: Becton Dickinson and Co. - Business segments; Exhibit 134: Becton Dickinson and Co. - Key news; Exhibit 135: Becton Dickinson and Co. - Key offerings; Exhibit 136: Becton Dickinson and Co. - Segment focus; 12.6 Biosensors International Group Ltd.; Exhibit 137: Biosensors International Group Ltd. - Overview; Exhibit 138: Biosensors International Group Ltd. - Product / Service; Exhibit 139: Biosensors International Group Ltd. - Key offerings; 12.7 BioVentrix Inc.; Exhibit 140: BioVentrix Inc. - Overview; Exhibit 141: BioVentrix Inc. - Product / Service; Exhibit 142: BioVentrix Inc. - Key offerings; 12.8 Boston Scientific Corp.; Exhibit 143: Boston Scientific Corp. - Overview; Exhibit 144: Boston Scientific Corp. - Business segments; Exhibit 145: Boston Scientific Corp. - Key news; Exhibit 146: Boston Scientific Corp. - Key offerings; Exhibit 147: Boston Scientific Corp. - Segment focus; 12.9 Cardio Medical GmbH; Exhibit 148: Cardio Medical GmbH - Overview; Exhibit 149: Cardio Medical GmbH - Product / Service; Exhibit 150: Cardio Medical GmbH - Key offerings; 12.10 Edwards Lifesciences Corp.; Exhibit 151: Edwards Lifesciences Corp. - Overview; Exhibit 152: Edwards Lifesciences Corp. - Business segments; Exhibit 153: Edwards Lifesciences Corp. - Key offerings; Exhibit 154: Edwards Lifesciences Corp. - Segment focus; 12.11 GE Healthcare Technologies Inc.; Exhibit 155: GE Healthcare Technologies Inc. - Overview; Exhibit 156: GE Healthcare Technologies Inc. - Business segments; Exhibit 157: GE Healthcare Technologies Inc. - Key offerings; Exhibit 158: GE Healthcare Technologies Inc. - Segment focus; 12.12 Intuitive Surgical Inc.; Exhibit 159: Intuitive Surgical Inc. - Overview; Exhibit 160: Intuitive Surgical Inc. - Product / Service; Exhibit 161: Intuitive Surgical Inc. - Key offerings; 12.13 Johnson and Johnson; Exhibit 162: Johnson and Johnson - Overview; Exhibit 163: Johnson and Johnson - Business segments; Exhibit 164: Johnson and Johnson - Key news; Exhibit 165: Johnson and Johnson - Key offerings; Exhibit 166: Johnson and Johnson - Segment focus; 12.14 LivaNova Plc; Exhibit 167: LivaNova Plc - Overview; Exhibit 168: LivaNova Plc - Business segments; Exhibit 169: LivaNova Plc - Key offerings; Exhibit 170: LivaNova Plc - Segment focus; 12.15 Medtronic Plc; Exhibit 171: Medtronic Plc - Overview; Exhibit 172: Medtronic Plc - Business segments; Exhibit 173: Medtronic Plc - Key news; Exhibit 174: Medtronic Plc - Key offerings; Exhibit 175: Medtronic Plc - Segment focus; 12.16 Richard Wolf GmbH; Exhibit 176: Richard Wolf GmbH - Overview; Exhibit 177: Richard Wolf GmbH - Product / Service; Exhibit 178: Richard Wolf GmbH - Key offerings; 12.17 Teleflex Inc.; Exhibit 179: Teleflex Inc. - Overview; Exhibit 180: Teleflex Inc. - Business segments; Exhibit 181: Teleflex Inc. - Key news; Exhibit 182: Teleflex Inc. - Key offerings; Exhibit 183: Teleflex Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 184: Inclusions checklist; Exhibit 185: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 186: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 187: Research methodology; Exhibit 188: Validation techniques employed for market sizing; Exhibit 189: Information sources; 13.5 List of abbreviations; Exhibit 190: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global thoracic surgery market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on End-user - Market share 2023-2028 (%); Exhibits31: Data Table on End-user - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by End-user ($ million); Exhibits47: Data Table on Market opportunity by End-user ($ million); Exhibits48: Chart on Product - Market share 2023-2028 (%); Exhibits49: Data Table on Product - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Product; Exhibits51: Data Table on Comparison by Product; Exhibits52: Chart on CRM and cardiac assist devices - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on CRM and cardiac assist devices - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on CRM and cardiac assist devices - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on CRM and cardiac assist devices - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Heart valve repair and replacement devices - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Heart valve repair and replacement devices - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Heart valve repair and replacement devices - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Heart valve repair and replacement devices - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Cardiopulmonary devices - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Cardiopulmonary devices - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Cardiopulmonary devices - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Cardiopulmonary devices - Year-over-year growth 2023-2028 (%); Exhibits64: Chart on Heart defect closure devices - Market size and forecast 2023-2028 ($ million); Exhibits65: Data Table on Heart defect closure devices - Market size and forecast 2023-2028 ($ million); Exhibits66: Chart on Heart defect closure devices - Year-over-year growth 2023-2028 (%); Exhibits67: Data Table on Heart defect closure devices - Year-over-year growth 2023-2028 (%); Exhibits68: Chart on Other thoracic surgery devices - Market size and forecast 2023-2028 ($ million); Exhibits69: Data Table on Other thoracic surgery devices - Market size and forecast 2023-2028 ($ million); Exhibits70: Chart on Other thoracic surgery devices - Year-over-year growth 2023-2028 (%); Exhibits71: Data Table on Other thoracic surgery devices - Year-over-year growth 2023-2028 (%); Exhibits72: Market opportunity by Product ($ million); Exhibits73: Data Table on Market opportunity by Product ($ million); Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits77: Chart on Geographic comparison; Exhibits78: Data Table on Geographic comparison; Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits107: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits108: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits109: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits110: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits111: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits112: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits113: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits114: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits115: Market opportunity By Geographical Landscape ($ million); Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits117: Impact of drivers and challenges in 2023 and 2028; Exhibits118: Overview on Criticality of inputs and Factors of differentiation; Exhibits119: Overview on factors of disruption; Exhibits120: Impact of key risks on business; Exhibits121: Vendors covered; Exhibits122: Matrix on vendor position and classification; Exhibits123: Abbott Laboratories - Overview; Exhibits124: Abbott Laboratories - Business segments; Exhibits125: Abbott Laboratories - Key news; Exhibits126: Abbott Laboratories - Key offerings; Exhibits127: Abbott Laboratories - Segment focus; Exhibits128: AbbVie Inc. - Overview; Exhibits129: AbbVie Inc. - Product / Service; Exhibits130: AbbVie Inc. - Key news; Exhibits131: AbbVie Inc. - Key offerings; Exhibits132: Becton Dickinson and Co. - Overview; Exhibits133: Becton Dickinson and Co. - Business segments; Exhibits134: Becton Dickinson and Co. - Key news; Exhibits135: Becton Dickinson and Co. - Key offerings; Exhibits136: Becton Dickinson and Co. - Segment focus; Exhibits137: Biosensors International Group Ltd. - Overview; Exhibits138: Biosensors International Group Ltd. - Product / Service; Exhibits139: Biosensors International Group Ltd. - Key offerings; Exhibits140: BioVentrix Inc. - Overview; Exhibits141: BioVentrix Inc. - Product / Service; Exhibits142: BioVentrix Inc. - Key offerings; Exhibits143: Boston Scientific Corp. - Overview; Exhibits144: Boston Scientific Corp. - Business segments; Exhibits145: Boston Scientific Corp. - Key news; Exhibits146: Boston Scientific Corp. - Key offerings; Exhibits147: Boston Scientific Corp. - Segment focus; Exhibits148: Cardio Medical GmbH - Overview; Exhibits149: Cardio Medical GmbH - Product / Service; Exhibits150: Cardio Medical GmbH - Key offerings; Exhibits151: Edwards Lifesciences Corp. - Overview; Exhibits152: Edwards Lifesciences Corp. - Business segments; Exhibits153: Edwards Lifesciences Corp. - Key offerings; Exhibits154: Edwards Lifesciences Corp. - Segment focus; Exhibits155: GE Healthcare Technologies Inc. - Overview; Exhibits156: GE Healthcare Technologies Inc. - Business segments; Exhibits157: GE Healthcare Technologies Inc. - Key offerings; Exhibits158: GE Healthcare Technologies Inc. - Segment focus; Exhibits159: Intuitive Surgical Inc. - Overview; Exhibits160: Intuitive Surgical Inc. - Product / Service; Exhibits161: Intuitive Surgical Inc. - Key offerings; Exhibits162: Johnson and Johnson - Overview; Exhibits163: Johnson and Johnson - Business segments; Exhibits164: Johnson and Johnson - Key news; Exhibits165: Johnson and Johnson - Key offerings; Exhibits166: Johnson and Johnson - Segment focus; Exhibits167: LivaNova Plc - Overview; Exhibits168: LivaNova Plc - Business segments; Exhibits169: LivaNova Plc - Key offerings; Exhibits170: LivaNova Plc - Segment focus; Exhibits171: Medtronic Plc - Overview; Exhibits172: Medtronic Plc - Business segments; Exhibits173: Medtronic Plc - Key news; Exhibits174: Medtronic Plc - Key offerings; Exhibits175: Medtronic Plc - Segment focus; Exhibits176: Richard Wolf GmbH - Overview; Exhibits177: Richard Wolf GmbH - Product / Service; Exhibits178: Richard Wolf GmbH - Key offerings; Exhibits179: Teleflex Inc. - Overview; Exhibits180: Teleflex Inc. - Business segments; Exhibits181: Teleflex Inc. - Key news; Exhibits182: Teleflex Inc. - Key offerings; Exhibits183: Teleflex Inc. - Segment focus; Exhibits184: Inclusions checklist; Exhibits185: Exclusions checklist; Exhibits186: Currency conversion rates for US$; Exhibits187: Research methodology; Exhibits188: Validation techniques employed for market sizing; Exhibits189: Information sources; Exhibits190: List of abbreviations